Sascha Haubner

7PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursGene and molecular therapyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 06, 2026
Dual CAR-T cell therapy targeting CD19 and BCMA as a novel opportunity for immune reset in systemic lupus erythematosus.

|Feb 26, 2026
Sensitive CAR T cells redefine targetable CD70 expression in solid tumors.

Sophie A Hanina, Tyler Park, Michael Lopez

|Dec 04, 2024
Honing CAR T cells to tackle acute myeloid leukemia.

Sascha Haubner, Marion Subklewe, Michel Sadelain

|Jan 14, 2022
HLA-independent T cell receptors for targeting tumors with low antigen density.

Jorge Mansilla-Soto, Justin Eyquem, Sascha Haubner

|Jun 11, 2020
Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid Leukemia.

Bettina Brauchle, Rebecca L Goldstein, Christine M Karbowski

|Mar 27, 2019
CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes.

Moritz Rapp, Maximilian W M Wintergerst, Wolfgang G Kunz

Pageof 2

Frequent Collaborators

4 joint publications

Michel Sadelain

2 joint publications

Jorge Mansilla-Soto

1 joint publications

T Herold

1 joint publications

Moritz Rapp